Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: Is it cost-effective? Article

cited authors

  • Phippen, Neil T.; Leath, Charles A., III; Havrilesky, Laura J.; Barnett, Jason C.

authors

Publication Date

  • January 1, 2015

webpage

published in

category

keywords

  • Bevacizumab
  • Cervical cancer
  • Cost-effectiveness

start page

  • 43

end page

  • 47

volume

  • 136

issue

  • 1